Anti-inflammatory effects of plumbagin are mediated by inhibition of NF-kappaB activation in lymphocytes

International Immunopharmacology

Volumn 9, Issue 7-8, 2009, Pages 949-958

  Checker, Rahul ^a   Sharma, Deepak ^a   Sandur, Santosh Kumar ^a   Khanam, Shazia ^b   Poduval, T B ^a  

^a BHABHA ATOMIC RESEARCH CENTRE   (India)

^b TATA INSTITUTE OF FUNDAMENTAL RESEARCH   (India)

Author keywords

Anti inflammatory; Cell cycle; Cytokines; Proliferation; T cell

Indexed keywords

CD69 ANTIGEN; CONCANAVALIN A; GAMMA INTERFERON; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; INTERLEUKIN 6; MITOGENIC AGENT; PLUMBAGIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL CYCLE PROGRESSION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; GRAFT VERSUS HOST REACTION; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; T LYMPHOCYTE ACTIVATION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELL CYCLE; CELL NUCLEUS; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; DOWN-REGULATION; GRAFT VS HOST DISEASE; I-KAPPA B PROTEINS; IMMUNOSUPPRESSION; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; MALE; MICE; NAPHTHOQUINONES; NF-KAPPA B; PLANT ROOTS; PLUMBAGINACEAE; T-LYMPHOCYTES; TRANSCRIPTIONAL ACTIVATION;

EID: 67349083623     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2009.03.022     Document Type: Article

References (34)

1. Krieger N.R., and Emre S. Novel immunosuppressants. Pediatr Transplant 8 6 (2004) 594-599
2. Sharma D., Kumar S.S., and Sainis K.B. Antiapoptotic and immunomodulatory effects of chlorophyllin. Mol Immunol 44 4 (2007) 347-359
3. Marczak L., Kawiak A., Lojkowska E., and Stobiecki M. Secondary metabolites in in vitro cultured plants of the genus Drosera. Phytochem Anal 16 3 (2005) 143-149
4. Lin L.C., Yang L.L., and Chou C.J. Cytotoxic naphthoquinones and plumbagic acid glucosides from Plumbago zeylanica. Phytochemistry 62 4 (2003) 619-622
5. Wang C.C., Chiang Y.M., Sung S.C., Hsu Y.L., Chang J.K., and Kuo P.L. Plumbagin induces cell cycle arrest and apoptosis through reactive oxygen species/c-Jun N-terminal kinase pathways in human melanoma A375.S2 cells. Cancer Lett 259 1 (2008) 82-98
6. Thasni K.A., Rakesh S., Rojini G., Ratheeshkumar T., Srinivas G., and Priya S. Estrogen-dependent cell signaling and apoptosis in BRCA1-blocked BG1 ovarian cancer cells in response to plumbagin and other chemotherapeutic agents. Ann Oncol 19 4 (2008) 696-705
7. Devi P.U., Rao B.S., and Solomon F.E. Effect of plumbagin on the radiation induced cytogenetic and cell cycle changes in mouse Ehrlich ascites carcinoma in vivo. Indian J Exp Biol 36 9 (1998) 891-895
8. Abdul K.M., and Ramchender R.P. Modulatory effect of plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) on macrophage functions in BALB/c mice. I. Potentiation of macrophage bactericidal activity. Immunopharmacology 30 3 (1995) 231-236
9. Murali P.M., Rajasekaran S., Paramesh P., Krishnarajasekar O.R., Vasudevan S., Nalini K., et al. Plant-based formulation in the management of chronic obstructive pulmonary disease: a randomized double-blind study. Respir Med 100 1 (2006) 39-45
10. Sun Z., and Andersson R. NF-kappaB activation and inhibition: a review. Shock 18 2 (2002) 99-106
11. Sandur S.K., Ichikawa H., Sethi G., Ahn K.S., and Aggarwal B.B. Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) suppresses NF-kappaB activation and NF-kappaB-regulated gene products through modulation of p65 and IkappaBalpha kinase activation, leading to potentiation of apoptosis induced by cytokine and chemotherapeutic agents. J Biol Chem 281 25 (2006) 17023-17033
12. Vodanovic-Jankovic S., Hari P., Jacobs P., Komorowski R., and Drobyski W.R. NF-kappaB as a target for the prevention of graft-versus-host disease: comparative efficacy of bortezomib and PS-1145. Blood 107 2 (2006) 827-834
13. Sun K., Welniak L.A., Panoskaltsis-Mortari A., O'Shaughnessy M.J., Liu H., Barao I., et al. Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib. Proc Natl Acad Sci U S A 101 21 (2004) 8120-8125
14. Smiley S.T., Csizmadia V., Gao W., Turka L.A., and Hancock W.W. Differential effects of cyclosporine A, methylprednisolone, mycophenolate, and rapamycin on CD154 induction and requirement for NFkappaB: implications for tolerance induction. Transplantation 70 3 (2000) 415-419
15. Finn P.W., Stone J.R., Boothby M.R., and Perkins D.L. Inhibition of NF-kappaB-dependent T cell activation abrogates acute allograft rejection. J Immunol 167 10 (2001) 5994-6001
16. Sharma D., Kumar S.S., Raghu R., Khanam S., and Sainis K.B. Differential modulation of mitogen driven proliferation and homeostasis driven proliferation of T cells by rapamycin, Ly294002 and chlorophyllin. Mol Immunol 44 11 (2007) 2831-2840
17. Campbell K.J., Rocha S., and Perkins N.D. Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B. Mol Cell 13 6 (2004) 853-865
18. Liou H.C., Jin Z., Tumang J., Andjelic S., Smith K.A., and Liou M.L. c-Rel is crucial for lymphocyte proliferation but dispensable for T cell effector function. Int Immunol 11 3 (1999) 361-371
19. Lord J.D., McIntosh B.C., Greenberg P.D., and Nelson B.H. The IL-2 receptor promotes proliferation, bcl-2 and bcl-x induction, but not cell viability through the adapter molecule Shc. J Immunol 161 9 (1998) 4627-4633
20. Mullen A.C., High F.A., Hutchins A.S., Lee H.W., Villarino A.V., Livingston D.M., et al. Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science 292 5523 (2001) 1907-1910
21. Schroder K., Hertzog P.J., Ravasi T., and Hume D.A. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75 2 (2004) 163-189
22. Zheng W., and Flavell R.A. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89 4 (1997) 587-596
23. Li-Weber M., and Krammer P.H. Regulation of IL4 gene expression by T cells and therapeutic perspectives. Nat Rev Immunol 3 7 (2003) 534-543
24. Weaver C.T., and Murphy K.M. The central role of the Th17 lineage in regulating the inflammatory/autoimmune axis. Semin Immunol 19 6 (2007) 351-352
25. Nishimoto N., and Kishimoto T. Inhibition of IL-6 for the treatment of inflammatory diseases. Curr Opin Pharmacol 4 4 (2004) 386-391
26. Wegener E., and Krappmann D. Dynamic protein complexes regulate NF-kappaB signaling. Handb Exp Pharmacol 186 (2008) 237-259
27. Lobry C., Lopez T., Israel A., and Weil R. Negative feedback loop in T cell activation through IkappaB kinase-induced phosphorylation and degradation of Bcl10. Proc Natl Acad Sci U S A 104 3 (2007) 908-913
28. Schulze-Luehrmann J., and Ghosh S. Antigen-receptor signaling to nuclear factor kappa B. Immunity 25 5 (2006) 701-715
29. Zhou H., Wertz I., O'Rourke K., Ultsch M., Seshagiri S., Eby M., et al. Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO. Nature 427 6970 (2004) 167-171
30. Shambharkar P.B., Blonska M., Pappu B.P., Li H., You Y., Sakurai H., et al. Phosphorylation and ubiquitination of the IkappaB kinase complex by two distinct signaling pathways. Embo J 26 7 (2007) 1794-1805
31. Paule B., Terry S., Kheuang L., Soyeux P., Vacherot F., and de la Taille A. The NF-kappaB/IL-6 pathway in metastatic androgen-independent prostate cancer: new therapeutic approaches?. World J Urol 25 5 (2007) 477-489
32. Sica A., Dorman L., Viggiano V., Cippitelli M., Ghosh P., Rice N., et al. Interaction of NF-kappaB and NFAT with the interferon-gamma promoter. J Biol Chem 272 48 (1997) 30412-30420
33. Ghosh S., May M.J., and Kopp E.B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16 (1998) 225-260
34. Li-Weber M., Giasi M., and Krammer P.H. Involvement of Jun and Rel proteins in up-regulation of interleukin-4 gene activity by the T cell accessory molecule CD28. J Biol Chem 273 49 (1998) 32460-32466